CROI 2014: Prevention
A panel discussion reviewing the most interesting prevention conversations at this years 21st CROI conference. Of note the panel identifies adherence to be the main issue with the one pill a day versions of PrEP. Questions about inconsistent sloppy use of PEP and PREP are identified as possible causes that might explain why in one study 25% of people showed up with HIV that are resistant to PEP medications. The development of once a month PrEP is on the horizon with the advent of drugs that can be dosed once a month or potentially less frequently.